German pharmaceutical company Stada Arzneimittel is intended to be fully acquired by either Cinven Partners and Advent International Corporation, which have both submitted bids.

“US-based biopharmaceutical company NexImmune has been fully acquired by a consortium of private investors.”

Both companies that bid for the acquisition are based in the US.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

US-based biopharmaceutical company NexImmune has been fully acquired by a consortium of private investors.

The acquisition will help NexImmune expand its portfolio in immuno-oncology and other immune-mediated disease areas.

The consortium, led by Celgene and CEOs of Medtronic, also includes other private investors.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now